Logo Logo

Publications by Escudier, Bernard

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Motzer, Robert J.; Ravaud, Alain; Patard, Jean-Jacques; Pandha, Hardev S.; George, Daniel J.; Patel, Anup; Chang, Yen-Hwa; Escudier, Bernard; Donskov, Frede; Magheli, Ahmed; Carteni, Giacomo; Laguerre, Brigitte; Tomczak, Piotr; Breza, Jan; Gerletti, Paola; Lechuga, Mariajose; Lin, Xun; Casey, Michelle; Serfass, Lucile; Pantuck, Allan J.; Stähler, Michael (2018): Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. In: European Urology, Vol. 73, No. 1: pp. 62-68

Schoffski, Patrick; Wozniak, Agnieszka; Escudier, Bernard; Rutkowski, Piotr; Anthoney, Alan; Bauer, Sebastian; Sufliarsky, Jozef; Herpen, Carla van; Lindner, Lars H.; Grünwald, Viktor; Zakotnik, Branko; Lerut, Evelyne; Debiec-Rychter, Maria; Marreaud, Sandrine; Lia, Michela; Raveloarivahy, Tiana; Collette, Sandra; Albiges, Laurence (2017): Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial. In: European Journal of Cancer, Vol. 87: pp. 147-163

Powles, Thomas; Lackner, Mark R.; Oudard, Stéphane; Escudier, Bernard; Ralph, Christy; Brown, Janet E.; Hawkins, Robert E.; Castellano, Daniel; Rini, Brian I.; Staehler, Michael D.; Ravaud, Alain; Lin, Wei; O'Keeffe, Bridget; Wang, Yulei; Lu, Shan; Spoerke, Jill M.; Huw, Ling-Yuh; Byrtek, Michelle; Zhu, Rui; Ware, Joseph A.; Motzer, Robert J. (2016): Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma. In: Journal of Clinical Oncology, Vol. 34, No. 14: 1660-U204

This list was generated on Sat Sep 21 17:43:51 2019 CEST.